Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biome Australia Ltd ( (AU:BIO) ) has provided an announcement.
Biome Australia Limited has announced a strategic partnership with Green Cross Health, New Zealand’s leading integrated healthcare provider. This collaboration allows Biome’s Activated Probiotics to be launched across New Zealand’s largest pharmacy network, comprising 328 stores under the Life Pharmacy and UniChem brands. The partnership is a significant step in Biome’s international expansion strategy, leveraging Green Cross Health’s extensive retail market penetration and Propharma’s wholesale distribution infrastructure. With New Zealand’s natural health products market growing and pharmacies capturing the majority of sales, this move positions Biome favorably in the market.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited operates in the healthcare industry, focusing on natural health products. The company is known for its Activated Probiotics line and is expanding its market presence internationally.
Average Trading Volume: 399,942
Technical Sentiment Signal: Strong Buy
Find detailed analytics on BIO stock on TipRanks’ Stock Analysis page.